Biomerica Company Profile (OTCMKTS:BMRA)

About Biomerica

Biomerica logoBiomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The Company operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company's diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The Company's diagnostic products use immunoassay technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: BMRA
  • CUSIP:
Key Metrics:
  • Previous Close: $2.83
  • 50 Day Moving Average: $2.86
  • 200 Day Moving Average: $46.82
  • 52-Week Range: $1.30 - $375.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.65
  • P/E Growth: 0.00
  • Market Cap: $23.12M
  • Outstanding Shares: 8,169,000
  • Beta: 0.27
Additional Links:
Companies Related to Biomerica:

Analyst Ratings

Consensus Ratings for Biomerica (OTCMKTS:BMRA) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biomerica (OTCMKTS:BMRA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biomerica (OTCMKTS:BMRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/30/2016        
10/15/2015($0.02)($0.01)ViewN/AView Earnings Details
4/15/2015($0.01)($0.02)ViewN/AView Earnings Details
1/16/2015($0.01)($0.03)ViewN/AView Earnings Details
10/17/2014($0.03)($0.03)ViewN/AView Earnings Details
9/3/2014$0.02$0.02ViewN/AView Earnings Details
1/15/2014Nov 2013($0.01)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biomerica (OTCMKTS:BMRA)
Current Year EPS Consensus Estimate: $-0.09 EPS
Next Year EPS Consensus Estimate: $-0.17 EPS

Dividends

Dividend History for Biomerica (OTCMKTS:BMRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biomerica (OTCMKTS:BMRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2016Zackary S IraniCEOBuy199$2.65$527.35View SEC Filing  
8/12/2016Janet MooreCFOBuy2,200$2.98$6,556.00View SEC Filing  
8/12/2016Zackary S IraniInsiderBuy3,166$2.98$9,434.68View SEC Filing  
8/11/2016Zackary S IraniCEOBuy3,700$2.88$10,656.00View SEC Filing  
8/10/2016Zackary S IraniCEOBuy1,000$2.72$2,720.00View SEC Filing  
8/9/2016Allen BarbieriDirectorBuy3,000$2.54$7,620.00View SEC Filing  
8/5/2016Francis CanoDirectorBuy16,300$2.37$38,631.00View SEC Filing  
8/3/2016Mark A SirgoDirectorBuy4,000$2.05$8,200.00View SEC Filing  
8/3/2016Zackary S IraniCEOBuy2,609$2.10$5,478.90View SEC Filing  
8/2/2016Mark A SirgoDirectorBuy8,000$1.97$15,760.00View SEC Filing  
8/1/2016Zackary S IraniCEOBuy5,400$1.88$10,152.00View SEC Filing  
5/16/2016Francis E CapitanioPresidentSell20,000$1.50$30,000.00View SEC Filing  
11/13/2015Zackary S IraniCEOBuy5,000$0.83$4,150.00View SEC Filing  
6/8/2015Zackary S IraniCEOBuy3,000$1.08$3,240.00View SEC Filing  
5/22/2015Zackary S IraniCEOBuy2,000$0.85$1,700.00View SEC Filing  
5/11/2015Zackary S IraniCEOBuy18,000$0.91$16,380.00View SEC Filing  
9/6/2012Zackary S IraniCEOBuy7,000$0.70$4,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biomerica (OTCMKTS:BMRA)
DateHeadline
finance.yahoo.com logoBMRA: Progress of InFoods Prompts Upward Revision to Valuation (OTCMKTS:BMRA)
finance.yahoo.com - September 6 at 3:37 PM
finance.yahoo.com logoProgress of InFoods Prompts Upward Revision to Valuation (OTCMKTS:BMRA)
finance.yahoo.com - September 6 at 3:37 PM
feeds.benzinga.com logoExclusive: Newly-Listed Biomerica's CEO Talks IBS, Tech And Patient Care (OTCMKTS:BMRA)
feeds.benzinga.com - September 6 at 2:55 PM
finance.yahoo.com logoBiomerica to Present at 18th Annual Rodman & Renshaw Global Investment Conference (OTCMKTS:BMRA)
finance.yahoo.com - September 6 at 8:44 AM
publicnow.com logoYear-End Results 2016 -- August 30, 2016 (OTCMKTS:BMRA)
www.publicnow.com - August 30 at 3:52 PM
4-traders.com logoBiomerica : Approved for Listing on the Nasdaq (OTCMKTS:BMRA)
www.4-traders.com - August 27 at 8:41 AM
publicnow.com logoBiomerica Approved for Listing on the Nasdaq (OTCMKTS:BMRA)
www.publicnow.com - August 26 at 3:50 PM
rttnews.com logoHEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN (OTCMKTS:BMRA)
www.rttnews.com - August 25 at 8:46 AM
marketwired.com logoBiomerica Approved for Listing on the Nasdaq Capital Market (OTCMKTS:BMRA)
www.marketwired.com - August 24 at 3:52 PM
streetinsider.com logoBiomerica, Inc. (BMRA) Cleared to List on Nasdaq CM (OTCMKTS:BMRA)
www.streetinsider.com - August 24 at 3:52 PM
finance.yahoo.com logo8:20 am Biomerica common stock has been approved for listing on the Nasdaq Capital Market, expects to commence trading on Aug 26 (OTCMKTS:BMRA)
finance.yahoo.com - August 24 at 12:08 PM
finance.yahoo.com logoBiomerica Updates Shareholders on Progress of Commercialization of Its New IBS Product (OTCMKTS:BMRA)
finance.yahoo.com - August 10 at 3:20 PM
4-traders.com logoBiomerica : Forms Strategic Advisory Board (OTCMKTS:BMRA)
www.4-traders.com - July 25 at 4:25 PM
publicnow.com logoBiomerica Forms Strategic Advisory Board (OTCMKTS:BMRA)
www.publicnow.com - July 25 at 3:28 PM
finance.yahoo.com logoBMRA: More Positive Clarity on InFoods' FDA Pathway (OTCMKTS:BMRA)
finance.yahoo.com - July 13 at 10:20 AM
marketwired.com logoFDA Determines That Biomerica's Proposed InFoods® IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study (OTCMKTS:BMRA)
www.marketwired.com - July 11 at 3:52 PM
finance.yahoo.com logoFDA Determines That Biomerica's Proposed InFoods(R) IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study (OTCMKTS:BMRA)
finance.yahoo.com - July 11 at 7:47 AM
capitalcube.com logoBiomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2016 By the Numbers : June 22, 2016 (OTCMKTS:BMRA)
www.capitalcube.com - June 22 at 11:02 AM
publicnow.com logoBiomerica Signs Exclusive License Agreement (OTCMKTS:BMRA)
www.publicnow.com - May 26 at 1:17 PM
finance.yahoo.com logoBiomerica Signs Exclusive License Agreement for Korean Market With Total Value of up to $8.5 Million; Licensee Makes Equity Investment of $1m in Biomerica at $3 per Share (OTCMKTS:BMRA)
finance.yahoo.com - May 26 at 9:09 AM
biz.yahoo.com logoBIOMERICA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (OTCMKTS:BMRA)
biz.yahoo.com - May 26 at 8:49 AM
capitalcube.com logoBiomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2016 By the Numbers (OTCMKTS:BMRA)
www.capitalcube.com - April 20 at 11:18 AM
publicnow.com logoBoard Members To Purchase Biomerica Common Stock (OTCMKTS:BMRA)
www.publicnow.com - April 15 at 5:47 PM
publicnow.com logo3rd Quarter Financials -- April 15, 2016 (OTCMKTS:BMRA)
www.publicnow.com - April 15 at 5:47 PM
finance.yahoo.com logoBiomerica Announces Third Quarter Financial Results, Sales up 10% for Nine Months (OTCMKTS:BMRA)
finance.yahoo.com - April 15 at 7:47 AM
finance.yahoo.com logoAll Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market (OTCMKTS:BMRA)
finance.yahoo.com - April 7 at 8:19 AM
biz.yahoo.com logoBIOMERICA INC Files SEC form 8-K, Other Events (OTCMKTS:BMRA)
biz.yahoo.com - March 16 at 6:07 AM
finance.yahoo.com logoBiomerica Announced That Its International Patent Application for IBS Was Reviewed by the ISA and All Claims Have Been Deemed Novel and Non-Obvious (OTCMKTS:BMRA)
finance.yahoo.com - March 14 at 8:19 AM
finance.yahoo.com logoBiomerica to Present at the ROTH Conference on March 16, 2016 (OTCMKTS:BMRA)
finance.yahoo.com - March 10 at 8:49 AM
News IconOxySure Launches Cardiac Safety eCommerce Store (OTCMKTS:BMRA)
secfilings.com - March 8 at 2:30 PM
News IconOxySure Expands Sales Team with Florida Manager (OTCMKTS:BMRA)
secfilings.com - January 28 at 1:48 PM
noodls.com logoBiomerica Announces Executive Advisor Appointment (OTCMKTS:BMRA)
www.noodls.com - January 20 at 3:15 PM
noodls.com logo2nd Quarter Financials -- January 15, 2016 (OTCMKTS:BMRA)
www.noodls.com - January 20 at 2:45 PM
finance.yahoo.com logoBMRA: Q2 Results, IBS Advisory Board Beefed Up Further (OTCMKTS:BMRA)
finance.yahoo.com - January 19 at 12:00 PM
finance.yahoo.com logoBiomerica Announces Second Quarter Financial Results (OTCMKTS:BMRA)
finance.yahoo.com - January 15 at 8:19 AM
finance.yahoo.com logoBiomerica Announces Executive Advisor Appointment for Medical Affairs and Research (OTCMKTS:BMRA)
finance.yahoo.com - January 8 at 7:11 AM
finance.yahoo.com logoOxySure (OXYS) Launches OxyTrac(TM) to Save Lives & Help Companies Stay Compliant (OTCMKTS:BMRA)
finance.yahoo.com - December 10 at 8:00 AM
finance.yahoo.com logoBIOMERICA INC Financials (OTCMKTS:BMRA)
finance.yahoo.com - December 8 at 1:16 PM
finance.yahoo.com logoBMRA: Q2 Results Inline. IBS May Go De Novo Pathway (OTCMKTS:BMRA)
finance.yahoo.com - October 20 at 10:30 AM
capitalcube.com logoBiomerica, Inc. Earnings Q1, 2016 (OTCMKTS:BMRA)
www.capitalcube.com - October 19 at 10:45 AM
finance.yahoo.com logoBiomerica Reports First Quarter Results; Sales Up Over 24% (OTCMKTS:BMRA)
finance.yahoo.com - October 16 at 8:19 AM
biz.yahoo.com logoBIOMERICA INC Files SEC form 10-Q, Quarterly Report (OTCMKTS:BMRA)
biz.yahoo.com - October 15 at 4:24 PM
finance.yahoo.com logoBiomerica Working With FDA on Submission for Its IBS Product (OTCMKTS:BMRA)
finance.yahoo.com - September 29 at 7:47 AM
noodls.com logoYear-End Results 2015 - September 1, 2015 (OTCMKTS:BMRA)
www.noodls.com - September 3 at 3:05 PM
finance.yahoo.com logoBMRA: Rebound of Asian Sales Driving Streak of Sequential Growth (OTCMKTS:BMRA)
finance.yahoo.com - September 3 at 10:30 AM
finance.yahoo.com logoBiomerica Announces Year End Results (OTCMKTS:BMRA)
finance.yahoo.com - September 1 at 8:19 AM
biz.yahoo.com logoBIOMERICA INC Files SEC form 10-K, Annual Report (OTCMKTS:BMRA)
biz.yahoo.com - August 31 at 4:24 PM
finance.yahoo.com logoBMRA: Additional Insight Into High-Profile IBS Product (OTCMKTS:BMRA)
finance.yahoo.com - July 27 at 1:45 PM
finance.yahoo.com logoBiomerica Announces Conference Call Regarding Its Product and Recent Developments in the Irritable Bowel Syndrome (IBS) Market (OTCMKTS:BMRA)
finance.yahoo.com - July 6 at 8:18 AM
finance.yahoo.com logoBiomerica Announces Its First Brazilian ANVISA Approvals and a New Distribution Channel in Brazil (OTCMKTS:BMRA)
finance.yahoo.com - June 29 at 8:19 AM

Social

Biomerica (OTCMKTS:BMRA) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff